NRX Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRXP and other ETFs, options, and stocks.About NRXP
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C.
CEOJonathan C. Javitt
CEOJonathan C. Javitt
Employees—
Employees—
HeadquartersWilmington, Delaware
HeadquartersWilmington, Delaware
Founded2017
Founded2017
Employees—
Employees—
NRXP Key Statistics
Market cap66.17M
Market cap66.17M
Price-Earnings ratio-1.00
Price-Earnings ratio-1.00
Dividend yield—
Dividend yield—
Average volume377.39K
Average volume377.39K
High today$2.48
High today$2.48
Low today$2.35
Low today$2.35
Open price$2.42
Open price$2.42
Volume204.60K
Volume204.60K
52 Week high$6.01
52 Week high$6.01
52 Week low$1.15
52 Week low$1.15
Stock Snapshot
NRX Pharmaceuticals(NRXP) stock is priced at $2.35, giving the company a market capitalization of 66.17M. It carries a P/E multiple of -1.00.
On 2025-12-06, NRX Pharmaceuticals(NRXP) stock moved within a range of $2.35 to $2.48. With shares now at $2.35, the stock is trading 0.0% above its intraday low and -5.2% below the session's peak.
Trading volume for NRX Pharmaceuticals(NRXP) stock has reached 204.6K, versus its average volume of 377.39K.
Over the past 52 weeks, NRX Pharmaceuticals(NRXP) stock has traded between a high of $6.01 and a low of $1.15.
Over the past 52 weeks, NRX Pharmaceuticals(NRXP) stock has traded between a high of $6.01 and a low of $1.15.
People also own
Based on the portfolios of people who own NRXP. This list is generated using Robinhood data, and it’s not a recommendation.